RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aquinox Pharma appoints two executives

AquinoxAquinox Pharmaceuticals, a clinical-stage pharmaceutical company, appoints Abigail L. Jenkins as chief commercial officer and Paul Brennan as VP, business development.
Article continues below

READ MORE Aquinox names Shelley McCloskey as VP

Ms. Jenkins has amassed nearly 20 years of commercial leadership experience spanning start-up Biotech enterprises to large Pharmaceutical companies. She specializes in launching brands into markets with high unmet clinical needs and brings expertise leading strategic marketing, sales, and market access functions.

Most recently Mrs. Jenkins served as Vice-President, Market Access at Relypsa. She previously served as Vice President, Business Development at Actavis, (now Allergan plc) as well as Senior Director of Marketing at MedImmune. She also brings eight years of senior marketing and sales experience with Pfizer Inc.

Mr. Brennan brings more than 25 years of experience in building and leading pharmaceutical and biotechnology companies in the United States, Europe and Canada with a strong track-record in partnering and licensing transactions.

Previously, Mr. Brennan was Senior Vice-President of Business Development at Arbutus Biopharma Corp. (formerly Tekmira Pharmaceuticals Corp.) prior to which he served as CEO of Altair Therapeutics.

He also served in senior business development and regulatory affairs roles with AstraZeneca PLC, operating in Sweden, the United Kingdom and Canada.

 LATEST MOVES FROM British Columbia 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy